CancerScreenDx™ is a multi-cancer early detection test that can detect over 110 types of cancer through a single blood draw. This test is unique in that it can detect many types of cancer that are not commonly screened by routine cancer biomarkers tests. When a cancer signal is detected, the CancerScreenDx™ test predicts the origin of the cancer signal with high accuracy to help guide the next steps to diagnosis. Using the CancerScreenDx™ test alongside existing screening tools is expected to improve early cancer detection for patients at an elevated risk of cancer, such as those aged 40 or older. This will help to identify cancer at an earlier stage, which can lead to improved outcomes for patients and reduced costs of treatment.